[HTML][HTML] A comprehensive review on phage therapy and phage-based drug development
L Cui, S Watanabe, K Miyanaga, K Kiga, T Sasahara… - Antibiotics, 2024 - mdpi.com
Phage therapy, the use of bacteriophages (phages) to treat bacterial infections, is regaining
momentum as a promising weapon against the rising threat of multidrug-resistant (MDR) …
momentum as a promising weapon against the rising threat of multidrug-resistant (MDR) …
M13 phage: a versatile building block for a highly specific analysis platform
R Wang, HD Li, Y Cao, ZY Wang, T Yang… - Analytical and …, 2023 - Springer
Viruses are changing the biosensing and biomedicine landscape due to their multivalency,
orthogonal reactivities, and responsiveness to genetic modifications. As the most extensively …
orthogonal reactivities, and responsiveness to genetic modifications. As the most extensively …
High-throughput analysis system of interaction kinetics for data-driven antibody design
R Matsunaga, K Ujiie, M Inagaki, J Fernández Pérez… - Scientific Reports, 2023 - nature.com
Surface plasmon resonance (SPR) is widely used for antigen–antibody interaction kinetics
analysis. However, it has not been used in the screening phase because of the low …
analysis. However, it has not been used in the screening phase because of the low …
Application of microfluidic technology in antibody screening
H Sun, N Hu, J Wang - Biotechnology Journal, 2022 - Wiley Online Library
Specific antibodies are widely used in the biomedical field. Current screening methods for
specific antibodies mainly involve hybridoma technology and antibody engineering …
specific antibodies mainly involve hybridoma technology and antibody engineering …
Microfluidics, an effective tool for supporting phage display-A review
L Li, H Yuan, Q Li, K Li, P Lin - Analytica Chimica Acta, 2024 - Elsevier
Phage display is a vital tool for the discovery and development of affinity reagents such as
antibodies and peptides, which have great potential in imaging, molecular recognition …
antibodies and peptides, which have great potential in imaging, molecular recognition …
Phage display technology and its impact in the discovery of novel protein-based drugs
CJ Hutchings, AK Sato - Expert Opinion on Drug Discovery, 2024 - Taylor & Francis
Introduction Phage display technology is a well-established versatile in vitro display
technology that has been used for over 35 years to identify peptides and antibodies for use …
technology that has been used for over 35 years to identify peptides and antibodies for use …
A mini review on recent progress of microfluidic systems for antibody development
K Omidfar, S Kashanian - Journal of Diabetes & Metabolic Disorders, 2024 - Springer
Objectives Antibody is specific reagent that be utilized in various field of biomedical
research. Monoclonal antibodies are mostly produced using two common techniques …
research. Monoclonal antibodies are mostly produced using two common techniques …
Methods for Engineering Binders to Multi-Pass Membrane Proteins
Numerous potential drug targets, including G-protein-coupled receptors and ion channel
proteins, reside on the cell surface as multi-pass membrane proteins. Unfortunately, despite …
proteins, reside on the cell surface as multi-pass membrane proteins. Unfortunately, despite …
High-throughput protein binder discovery by rapid in vivo selection
MJ Styles, JA Pixley, T Wei, C Basile, SS Lu… - bioRxiv, 2025 - biorxiv.org
Proteins that selectively bind to a target of interest are foundational components of research
pipelines,, diagnostics, and therapeutics. Current immunization-based,, display-based–, and …
pipelines,, diagnostics, and therapeutics. Current immunization-based,, display-based–, and …
Beyond Natural Immune Repertoires: Synthetic Antibodies
Synthetic antibody libraries, in which the antigen-binding sites are precisely designed, offer
unparalleled precision in antibody engineering, exceeding the potential of natural immune …
unparalleled precision in antibody engineering, exceeding the potential of natural immune …